In addition, we showed previously that already on day four of treatment, 80 genes were differentially expressed, one of them being NFKBIZ [13], which encodes for a nuclear inhibitor of NF-κB, shown to be an important regulator of psoriasis progression [14]. The gene discussed is NFKB1; the disease is psoriasis.